| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/16/2009 | EP2099444A1 Use of d-serine derivatives for the treatment of anxiety disorders |
| 09/16/2009 | EP2099441A1 Metal delivery agents and therapeutic uses of the same |
| 09/16/2009 | EP2099439A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/16/2009 | EP1893185B1 USE OF UROKINASE INHIBITORS FOR THE TREATMENT AND/OR PREVENTION OF AMYOTROPhIC LATERAL SCLEROSIS (ALS) |
| 09/16/2009 | EP1858865B1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 09/16/2009 | EP1817029B1 Isoxazolic derivative to relieve neuropathic pain |
| 09/16/2009 | EP1706106B9 Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances |
| 09/16/2009 | EP1608635B1 Phenyl sulfone derivatives and their use in the treatment of cns disorders |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1192125B9 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 09/16/2009 | EP0975595B9 Analogs of cocaine |
| 09/16/2009 | CN101531995A Method for cultivating and increasing human embryo neural stem cells |
| 09/16/2009 | CN101531717A Anti-Alzheimer disease monoclonal antibody and application thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531703A Beta lamellar blocking peptide for preventing and/or curing Alzheimer's disease |
| 09/16/2009 | CN101531697A Method for preparing sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and novel pharmaceutical application of the sarsasapogenin in the rhizoma anemarrhenae and the derivatives thereof |
| 09/16/2009 | CN101531689A Method for extracting gastrodin by biological enzyme method |
| 09/16/2009 | CN101531653A Salts of 3-(4-amino-1-oxo-1,3-dihydro-iso-indol-2-yl)piperdine-2,6-dione and derivatives thereof, polymorph of the salts, preparation and application thereof |
| 09/16/2009 | CN101531634A High-purity blonanserin and preparation method thereof |
| 09/16/2009 | CN101531570A 1,2,3-substituted-5-acetylenyl-(or 10,11-dihydro)-5H-diphenyl[a,d] suberne (alkyl)-5-alcohol, synthesizing method and application |
| 09/16/2009 | CN101530611A The new function of I-kallikrein in preparing the medicine for curing secondary damage of brain damage after remote part |
| 09/16/2009 | CN101530599A A pharmaceutical composition for treating mental depression |
| 09/16/2009 | CN101530593A Traditional Chinese medicine for treating diabetic numbness of extremities |
| 09/16/2009 | CN101530591A A Chinese medicine capsule having functions of tonify Qi, enliven the spleen and quiet the spirit and its preparation method |
| 09/16/2009 | CN101530587A Medicament for treating abasia and rheumatism |
| 09/16/2009 | CN101530579A A pharmaceutical composition for soothing the nerves |
| 09/16/2009 | CN101530553A Pharmaceutical composition with effects of tranquilizing and allaying excitement and preparation method thereof |
| 09/16/2009 | CN101530542A Oral pharmaceutical preparation of chinaroot greenbrier total aglycon and preparation method and application thereof |
| 09/16/2009 | CN101530533A Oral pharmaceutical preparation of dioscorea zingiberensis wright total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530532A Oral pharmaceutical preparation of yam total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530531A Panwang vigor pill for improving the functions of human body and preparation method thereof |
| 09/16/2009 | CN101530500A Therapeutic effect of blood-nourishing and brain-refreshing granules on trauma of cerebral nerve cell |
| 09/16/2009 | CN101530499A Prevention effect of blood-nourishing and brain-refreshing granules on trauma of cerebral nerve cell |
| 09/16/2009 | CN101530498A Improvement effect of blood-nourishing and brain-refreshing granules on cerebral microcirculatory disturbance |
| 09/16/2009 | CN101530441A Chinese medicine composition capable of treating insomnia |
| 09/16/2009 | CN101530413A Combined medicament for treating headache |
| 09/16/2009 | CN101530412A Pharmaceutical composition of blonanserin and preparation method thereof |
| 09/16/2009 | CN101530410A Application of oligomeric proantho cyanidins in preparing products resisting vascular dementia |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN101530040A Essential plant fragrance smell area capable of improving depression symptoms and construction method thereof |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540533C Crystalline forms of optical enantiomers of modafinil and method for the production |
| 09/16/2009 | CN100540004C Nasal pharmaceutical composition of piribedil |
| 09/15/2009 | US7589237 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| 09/15/2009 | US7589219 2,5-bis-diamine-[1,4]benzoquinonic derivatives, useful for the treatment of alzheimer's disease, method for preparing them and intermediates of said method |
| 09/15/2009 | US7589189 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 09/15/2009 | US7589170 Synthesis of cyclic peptides |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589113 Substituted oxadiazole compounds and their use as opioid receptor ligands |
| 09/15/2009 | US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors |
| 09/15/2009 | US7589105 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 09/15/2009 | US7589097 Using compounds such as 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine for therapy of Parkinson's disease; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589093 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | CA2522323C 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2439879C C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
| 09/15/2009 | CA2429220C Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 09/15/2009 | CA2419397C Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 09/15/2009 | CA2409819C Triazole derivatives |
| 09/15/2009 | CA2395774C New polymorphic forms of olanzapine |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/15/2009 | CA2364665C Phenyl- and pyridinyl derivatives |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2359463C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2340021C Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis |
| 09/15/2009 | CA2330330C Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2204433C Use of neurite localized mrnas for medical diagnosis and therapeutics |
| 09/15/2009 | CA2168203C Medicinal for protection from neurological damage |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/11/2009 | WO2009111739A2 Treatment of herpes virus related diseases |
| 09/11/2009 | WO2009111550A1 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloal kanes |
| 09/11/2009 | WO2009111449A1 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo [4,3-e] -1,2,4-triazolo [4,3-c] pyrimidin-3-one compounds for use as adenosine a2a receptor antagonists |
| 09/11/2009 | WO2009111442A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 09/11/2009 | WO2009111264A2 Systemic purine administration:modulating axonal outgrowth of central nervous system neurons |
| 09/11/2009 | WO2009110901A1 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof as allosteric modulators of mglur |
| 09/11/2009 | WO2009110844A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof |
| 09/11/2009 | WO2009110612A1 New compound derived from germinated brown rice, and agent containing said compound as an active ingredient for prevention or amelioration of neuropathy |
| 09/11/2009 | WO2009110526A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 3',5-di-2-propenyl-(1,1'-biphenyl)-2,4'-diol as active ingredient |
| 09/11/2009 | WO2009110351A1 Transdermally absorbable preparation |
| 09/11/2009 | WO2009109911A1 Methods of treating chronic pain |
| 09/11/2009 | WO2009109908A1 Methods of treating inflammatory pain |
| 09/11/2009 | WO2009109844A1 Methods, dosage forms, and kits for administering ziprasidone without food |
| 09/11/2009 | WO2009109710A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
| 09/11/2009 | WO2009109618A2 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109613A2 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109608A1 Novel compounds |
| 09/11/2009 | WO2009109502A1 2-aminoquinolines |